Showing results (361-370 of 407) with videos related to
Sort By:
Pageof 41
Journal of Neurology|July 22, 2015
Frequent misdiagnosis of adult polyglucosan body diseaseMark A Hellmann, Or Kakhlon, Ezekiel H Landau, et al.JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.Journal of Parkinson'S Disease|February 20, 2025
The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriersOrly Goldstein, Shachar Shani, Mali Gana-Weisz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2015
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneAnat Mirelman, Roy N Alcalay, Rachel Saunders-Pullman, et al.Parkinsonism & Related Disorders|August 29, 2024
Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutationsAvner Thaler, Saar Anis, Penina Ponger, et al.JAMA Neurology|January 9, 2018
Progression in the LRRK2-Asssociated Parkinson Disease PopulationRachel Saunders-Pullman, Anat Mirelman, Roy N Alcalay, et al.Parkinsonism & Related Disorders|July 9, 2010
Piloting the NPF data-driven quality improvement initiativeMichael S Okun, Andrew Siderowf, John G Nutt, et al.Neurology|March 29, 2013
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson diseaseZiv Gan-Or, Laurie J Ozelius, Anat Bar-Shira, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 4, 2017
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Mika Leinonen, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2018
Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriersAnat Mirelman, Rachel Saunders-Pullman, Roy N Alcalay, et al.Pageof 41